title: American Chemical Society - 229th National Meeting: bench to pilot plant.
authors.affiliation: Lexicon Pharmaceuticals Inc, Princeton, NJ 08540, USA. drotella@lexpharma.com
authors.forename: David P
authors.initials: DP
authors.lastname: Rotella
mesh_terms: D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D001249:Asthma / Q000188:drug therapy; D002626:Chemistry, Pharmaceutical / Q000379:methods* / Q000639:trends; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D010726:Phosphodiesterase Inhibitors / Q000138:chemical synthesis / Q000627:therapeutic use; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D012958:Societies, Scientific; D013678:Technology, Pharmaceutical / Q000379:methods / Q000592:standards / Q000639:trends; D014481:United States
chemical_list: D010726:Phosphodiesterase Inhibitors; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4